tyrphostin ag 1024 has been researched along with Acute Lymphoid Leukemia in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weston, VJ | 1 |
Wei, W | 1 |
Stankovic, T | 1 |
Kearns, P | 1 |
1 other study available for tyrphostin ag 1024 and Acute Lymphoid Leukemia
Article | Year |
---|---|
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.
Topics: Butadienes; Cell Cycle; Chromones; Daunorubicin; Down-Regulation; Drug Synergism; Gene Expression Pr | 2018 |